BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3349862)

  • 21. [Clinical effect of cefroxadine on surgical infections].
    Aikawa T; Noguchi S; Fujimoto N; Mizushima H; Shibata N; Tomita N; Horii A
    Jpn J Antibiot; 1983 Sep; 36(9):2521-8. PubMed ID: 6686263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical evaluation of cefroxadine in surgical infections].
    Hirayama T; Kikuchi K
    Jpn J Antibiot; 1983 Jun; 36(6):1435-8. PubMed ID: 6655799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peritonsillar abscess: clinical aspects of microbiology, risk factors, and the association with parapharyngeal abscess.
    Klug TE
    Dan Med J; 2017 Mar; 64(3):. PubMed ID: 28260599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Laboratory and clinical studies cefroxadine in pediatric field (author's transl)].
    Kawamura Y; Nomura T; Ihara T; Shimizu S; Kamiya H; Sakurai M; Nishi H
    Jpn J Antibiot; 1981 Dec; 34(12):1655-62. PubMed ID: 7334590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experimental and clinical evaluation of cefroxadine in the field of obstetrics and gynecology].
    Cho N; Araki H; Ishikawa T; Kunii K; Fukunaga K; Deguchi K
    Jpn J Antibiot; 1983 Sep; 36(9):2535-48. PubMed ID: 6655868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical evaluation of cefroxadine dry syrup in pediatric field (author's transl)].
    Minamitani M; Hachimori K; Suzuki M; Minamikawa I
    Jpn J Antibiot; 1981 Dec; 34(12):1626-33. PubMed ID: 7334587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of phenoxymethylpenicillin in tonsils.
    Roos K; Grahn E; Ekedahl C; Holm SE
    Scand J Infect Dis; 1986; 18(2):125-30. PubMed ID: 3085212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical trials with cefroxadine dry syrup in the treatment of infectious disease of children (author's transl)].
    Furukawa S; Okada T; Hirao F
    Jpn J Antibiot; 1981 Dec; 34(12):1697-702. PubMed ID: 7038188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study on the transfer of cefroxadine to human tears].
    Hara J; Tanaka Y; Harino S; Deguchi K
    Jpn J Antibiot; 1985 Feb; 38(2):230-4. PubMed ID: 4009946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cefroxadine in the treatment of children affected by respiratory and ENT diseases. A multicentre study involving 1072 in-patients.
    Scaglione F; Cattaneo G; Bianchi MM; Verdecchia P; Maresca V; Bichisao E; Fraschini F
    Drugs Exp Clin Res; 1989; 15(2):71-6. PubMed ID: 2737082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concentrations of azithromycin in human tonsillar tissue.
    Foulds G; Chan KH; Johnson JT; Shepard RM; Johnson RB
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):853-6. PubMed ID: 1662631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A parallel comparative double blind study of cefixime with cefroxadine in the treatment of acute lacunar tonsillitis].
    Matsunaga T; Ogino H; Asai H; Shiraishi T; Kawamura S; Onishi S; Ueda R; Kobayashi K; Itoh Y; Sakamoto Y
    Jpn J Antibiot; 1987 Jan; 40(1):25-54. PubMed ID: 3295323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tonsillar tissue penetration of dirithromycin after multiple doses.
    Benson JM; Arnold J; Manning SC; Coleman DL; Sides GD; Conforti PM; Lemon E; Watkins VS
    J Clin Pharmacol; 1996 Sep; 36(9):832-7. PubMed ID: 8889904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacteriologic comparison of tonsil core in recurrent tonsillitis and tonsillar hypertrophy.
    Jeong JH; Lee DW; Ryu RA; Lee YS; Lee SH; Kang JO; Tae K
    Laryngoscope; 2007 Dec; 117(12):2146-51. PubMed ID: 17909446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum concentrations of cephalosporins and the cell saver in cardiopulmonary bypass surgery.
    Rooney R; Neligan MC; Hone R; Murray A
    J Antimicrob Chemother; 1988 Aug; 22(2):266-8. PubMed ID: 3182423
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical effect and transfer into the wound exudate of cefroxadine used in the treatment of soft tissue infection].
    Takata N; Yamada T; Kubota T; Kaneko T
    Jpn J Antibiot; 1983 Sep; 36(9):2529-34. PubMed ID: 6655867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elimination of cefroxadine (CGP-9000) from patients undergoing dialysis.
    Nieto MJ; Lanao JM; Dominguez-Gil A; Tabernero JM; Macias JF
    Eur J Clin Pharmacol; 1983; 24(1):109-12. PubMed ID: 6832192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Penicillin V, loracarbef and clindamycin in tonsillar surface fluid during acute group A streptococcal pharyngotonsillitis.
    Orrling A; Kamme C; Stjernquist-Desatnik A
    Scand J Infect Dis; 2005; 37(6-7):429-35. PubMed ID: 16012002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of cefroxadine in the field of pediatrics (author's transl)].
    Iwai N; Sasaki A; Taneda Y; Inokuma K; Nakamura H
    Jpn J Antibiot; 1981 Dec; 34(12):1663-79. PubMed ID: 7334591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fundamental and clinical studies of cefroxadine in pediatric field (author's transl)].
    Toyonaga Y; Kurosu Y; Hori M; Kohno S
    Jpn J Antibiot; 1981 Dec; 34(12):1608-25. PubMed ID: 7334586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.